{
  "docId": "019dd923-622c-750b-8b98-e0497bacd3c2",
  "docSlug": "44aa04154472",
  "documentTitle": "Align Technology, Inc. (ALGN)",
  "authorId": "54_Spruce_Point_Capital",
  "authorName": "Ben Axler",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2020-04-09 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 8,
  "pageCount": 84,
  "prevPage": 7,
  "nextPage": 9,
  "slideType": "thesis_headline",
  "function": "summarize",
  "density": "overcrowded",
  "nDataPoints": 8,
  "notes": "The slide uses bolded headers for each of the five key arguments.",
  "elementsJson": [
    "headline_text",
    "paragraph"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b98-e0497bacd3c2/8",
  "deckHref": "/decks/019dd923-622c-750b-8b98-e0497bacd3c2",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b98-e0497bacd3c2.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-e0497bacd3c2#slide-8",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "Spruce Point sees 40%-55% downside in ALGN to $80-$115 per share on disappointing case volume growth in FY21 and ongoing ASP pressure amidst an expanded competitive landscape.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-0391-77f4-a9e2-c532028da0ab",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.2,
        "x": 0.05,
        "y": 0.04
      },
      "kind": "image",
      "text": "Spruce Point Capital Management",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c957ffd2-00ab-422c-8990-ace8f3de9dc6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "share price downside: 40%-55%",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd953-0391-77f4-a9e2-cb19296eff78",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.13,
        "w": 0.9,
        "x": 0.05,
        "y": 0.83
      },
      "kind": "paragraph",
      "text": "Not A Post-Pandemic Bounce Back Candidate, Even As Shares Trade Down: As ALGN shares trade lower with the market as the pandemic grows increasingly drawn-out, bulls with faith in the long-term growth story likely see the stock as a strong \"buy low\" opportunity...",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2c75a71b-4912-4785-be67-a635fa27c97a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.9,
        "x": 0.05,
        "y": 0.32
      },
      "kind": "paragraph",
      "text": "Growth Into The Purported TAM Will Be More Difficult Than Expected: Management claims that Align captures just 1.5M of over 8M annual worldwide malocclusion cases which Invisalign can be used to treat, and that there are more than 300M additional candidates...",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "63cb7596-2c39-4c4f-b06c-d3910576100b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.9,
        "x": 0.05,
        "y": 0.16
      },
      "kind": "paragraph",
      "text": "Widespread Dissatisfaction With Align Could Accelerate Customer Losses: Align bulls are quick to argue that the Company's brand and practitioner network protect it from new competition. We find that orthodontists are, almost universally, anywhere from dissatisfied to infuriated with Align...",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7514ffbd-8154-4da5-b9de-f019725ed35f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.9,
        "x": 0.05,
        "y": 0.48
      },
      "kind": "paragraph",
      "text": "Management Reducing Transparency While Showing Little Confidence In The Business: After reducing disclosures which would have made it easier for investors to see the impact of competitive pressures on Company results, management expanded a number of risk factors...",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "858e210d-d5d3-4ca6-9d94-a88727778f90",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.18,
        "w": 0.9,
        "x": 0.05,
        "y": 0.64
      },
      "kind": "paragraph",
      "text": "COVID-19 Pandemic Poses Unique Short-Term Risk, While Competitive Threats Could Inhibit Rebound: Shares in ALGN have largely traded in-line with the market as investors bet on when restrictions on normal economic activity will be lifted. However, with clear aligner therapy...",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d4cf164f-154b-41cf-b6a9-bc2dd2c3d899",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.65,
        "x": 0.28,
        "y": 0.05
      },
      "kind": "title",
      "text": "Short ALGN: Spruce Point Sees 40%-55% Downside To $80-$115 Per Share",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b4a977b0-1da8-4b8b-a67b-e0857299877c",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 10,
      "from": 1,
      "beatId": "e3718332-64cf-4420-af69-f6d54b5f8995",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Problem (Identify pain)",
      "beatSlug": "problem-agitate-solution-problem-identify-pain",
      "evidence": "The document introduces the short sell opinion and highlights the competitive pressures and pandemic-related risks facing Align Technology.",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}